Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

xray image of human lung

A Vaccine for Lung Cancer

MP3 WAV

  • Despite a drop in smoking, the number of new lung cancer cases continues to climb. It’s among the more deadly cancers with more Americans dying from it than any other cancer. Fortunately, a new vaccine to treat lung cancer is being tested. There are two main types of lung cancer, non-small cell and small cell.

    So how does this cancer vaccine work?  Even though our immune cells recognize and kill abnormal cancer cells, they may not get all of them. Cancer cells are good at evolving to escape immune detection.  If the tumor gets too large, the immune system can’t eliminate it. However, the new vaccine can enhance this immune response through messenger RNA or mRNA. They’re naturally made in the cell nucleus, leave with a blueprint for making proteins, and head to the ribosomes which read and translate them into proteins.  

    The vaccine delivers lab-made mRNAs with lung cancer antigens that teach the immune system to recognize and attack lung cancer cells. The BNT116 vaccine, as it is called, won’t replace standard treatments, especially at late stages.  It will complement surgery, chemotherapy, or immunotherapy.  

    A clinical trial is happening at three dozen sites across seven countries. More than 100 patients are receiving weekly shots for six weeks and then intermittent shots for about a year to see how well the vaccine works. The hope is that it’ll be effective in the early stages and lower the chance of recurrence. Improving both would help save many lives.   

More Information

How BioNTech’s “revolutionary” lung cancer vaccine actually works
The promising new treatment builds on research that went into developing COVID vaccines. Lung cancer is the leading cause of cancer deaths worldwide. A lung cancer vaccine developed by Germany-based BioNTech uses mRNA technology to train the immune system to detect and destroy cancer cells. Currently in trials, the vaccine aims to complement existing treatments and could help reduce recurrence in early-stage cancer.

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.